CA9 and esophageal squamous cell carcinoma: To choose the most potent inhibitor of CAIX expression in ESCC cell line, we treated ECA-109 cells with three sulfonamides (ACTZ, S4, and U104) at 4 mg/mL for 12 h under hypoxic conditions.